Case Details
- Citation: [2020] SGHC 142
- Case Title: OUE Lippo Healthcare Ltd (formerly known as International Healthway Corp Ltd) and another v Crest Capital Asia Pte Ltd and others
- Court: High Court of the Republic of Singapore
- Date of Decision: 09 July 2020
- Judge: Hoo Sheau Peng J
- Case Number: Suit No 441 of 2016
- Coram: Hoo Sheau Peng J
- Plaintiffs/Applicants: OUE Lippo Healthcare Ltd (formerly known as International Healthway Corp Ltd) and another
- Defendants/Respondents: Crest Capital Asia Pte Ltd and others
- Key Parties (as described): IHC (OUE Lippo Healthcare Ltd / International Healthway Corp Ltd); IHC Medical Re Pte Ltd; Crest entities (Crest Capital Asia Pte Ltd, Crest Catalyst Equity Pte Ltd, EFIII, VMF3, VMIII); individuals including Mr Fan Kow Hin, Ms Lim Beng Choo, and Mr Andrew Ah Kong Aathar
- Legal Areas: Companies — Directors; Companies — Capital; Tort — Conspiracy
- Statutes Referenced: Bankruptcy Act (Cap 20, 2009 Rev Ed); Companies Act (Cap 50, 2006 Rev Ed)
- Procedural Posture: Trial on both liability and quantum (with bifurcation for one category of loss relating to termination and sale of the plaintiffs’ Australian business)
- Notable Post-Trial Development: Court of Appeal decision in The Enterprise Fund III Ltd and others v OUE Lippo Healthcare Ltd (formerly known as International Healthway Corp Ltd) [2019] 2 SLR 524 released after trial but before closing/reply submissions; held the Standby Facility void under s 76A(1)(a) for contravention of s 76(1A)(a)(i)
- Counsel for Plaintiffs: Lee Eng Beng SC, Cheng Wai Yuen Mark, Chow Chao Wu Jansen, Danitza Hon Cai Xia and Sasha Gonsalves (Rajah & Tann Singapore LLP)
- Counsel for First to Fifth Defendants: Manoj Pillay Sandrasegara, Chng Zi Zhao Joel, Tan Kai Yun and Wong Zheng Hui Daryl (WongPartnership LLP)
- Counsel for Sixth Defendant: Unrepresented
- Counsel for Eighth Defendant: Goh Kok Leong, Ng Weiting and Daniel Tan An Ye (Ang & Partners)
- Judgment Length: 83 pages; 41,205 words
Summary
This High Court decision concerns a dispute arising from a corporate financing arrangement used in the mid-2010s by OUE Lippo Healthcare Ltd (then International Healthway Corp Ltd, “IHC”) and its controllers. The plaintiffs alleged that certain directors/officers and other participants caused IHC to enter into a “Standby Facility” credit arrangement, and to use the facility’s funds indirectly to acquire IHC’s own shares—conduct that, as later confirmed by the Court of Appeal, contravened the statutory prohibition on a company providing financial assistance for the acquisition of its own shares.
The plaintiffs advanced three main causes of action: (1) breach of fiduciary and statutory/company duties by two key individuals (Mr Fan and Ms Lim) as officers of IHC; (2) dishonest assistance by the “Crest entities” and other participants; and (3) conspiracy by unlawful means to injure IHC. The court also had to address issues of agency, accessory liability in equity, and the quantification of losses, including losses connected to a separate “Geelong Facility” and consequential losses from the termination and sale of IHC’s Australian business.
While the extract provided is truncated, the judgment’s framing makes clear that the court’s analysis was strongly influenced by the Court of Appeal’s earlier determination in The Enterprise Fund III Ltd v OUE Lippo Healthcare Ltd [2019] 2 SLR 524 that the Standby Facility was void for statutory illegality. The High Court therefore treated the legality of the Standby Facility as a central factual and legal anchor for assessing liability and remedies.
What Were the Facts of This Case?
IHC was a Singapore-incorporated listed company on the Catalist board of the Singapore Exchange. Its corporate structure included a wholly-owned subsidiary, IHC Medical Re Pte Ltd (“IHC Medical Re”), which served as the ultimate holding company for IHC’s Australian business through IHC Healthcare REIT (Singapore Trust). The Australian business was concentrated in three properties in Victoria, Australia: two St Kilda Road properties in Melbourne and a Geelong property at Little Ryrie Street. IHC also held other subsidiaries involved in management and operations, including IHC Management Pte Ltd and IHC Management (Australian) Pty Ltd.
Two founders/controllers of IHC were Mr Fan Kow Hin and Mr Andrew Ah Kong Aathar. Mr Fan had formal executive roles: he was appointed Group Chief Executive Officer in May 2015 and later re-designated as Chief Executive Officer in June 2015, remaining until January 2016. Mr Aathar, by contrast, did not hold a formal position but was a substantial shareholder. The plaintiffs’ case also relied on Ms Lim Beng Choo, who held senior financial and investment roles before being appointed CEO and Executive Director in January 2016. The court’s analysis of duties and “shadow director” concepts (as reflected in the case metadata) indicates that the plaintiffs’ allegations were not limited to formal office-holders.
On the funding side, the defendants included a group of entities associated with Crest Capital Asia Pte Ltd (“Crest Capital”) and Crest Catalyst Equity Pte Ltd (“Crest Catalyst”), which administered and managed affiliated private equity funds. The relevant funds were The Enterprise Fund III Ltd (“EFIII”), VMF3 Ltd (“VMF3”), and Value Monetisation III Ltd (“VMIII”). The Crest entities’ investment director, Mr Tan Yang Hwee (also known as Glendon Tan), was described as the main representative handling Crest’s dealings with IHC, including the transactions that led to both the Standby Facility and the Geelong Facility.
The Standby Facility was a short-term credit facility of up to S$20 million granted to IHC by EFIII, VMF3 and VMIII. The agreement was executed on 30 July 2015, with an initial agreement executed earlier and backdated to April 2015, and then superseded. The facility was described as “general working capital” and provided for fixed “standby fees” on the full sum, with default interest on unpaid amounts. The Geelong Facility was a mezzanine loan of S$11.5 million granted to IHC Medical Re by EFIII and VMIII, intended to partially finance acquisition of the Australian properties, with interest and default interest terms.
Crucially, both facilities were secured by personal guarantees from Mr Fan and Mr Aathar and by charges granted by IHC over shares in its subsidiaries (the “Charged Shares”). The plaintiffs alleged that a dispute over the Standby Facility triggered default under the Geelong Facility, leading to further consequential losses. The plaintiffs’ core narrative, however, was that the Standby Facility was not genuinely for working capital or defensive purposes against short-selling, but was used indirectly to enable IHC to acquire its own shares—an arrangement that the Court of Appeal later held to be void for statutory illegality.
What Were the Key Legal Issues?
The first legal issue concerned whether Mr Fan and Ms Lim, as officers of IHC, breached duties owed to the company. This involved questions about the scope of fiduciary duties and whether the individuals’ conduct amounted to improper use of corporate power, including whether their roles could be characterised as “shadow directorship” or otherwise as conduct attributable to officers for the purpose of breach of duty analysis. The court also had to consider how the officers’ knowledge and intent related to the alleged improper purpose of the Standby Facility.
The second issue was whether the Crest entities and other participants provided “dishonest assistance” to Mr Fan (and/or other wrongdoers). Dishonest assistance in equity requires proof that the assistant knowingly participated in a breach of duty, with the requisite dishonesty. The court therefore had to examine the nature of the Crest entities’ involvement, the communications and documentation surrounding the Standby Facility, and whether the Crest entities acted with the knowledge and state of mind necessary to attract accessory liability.
The third issue was tortious conspiracy by unlawful means. The plaintiffs alleged that all defendants engaged in a conspiracy to injure IHC. This required the court to determine whether there was an agreement or combination among the defendants, and whether the means used were unlawful in the relevant sense. The court also had to connect the alleged conspiracy to the losses claimed, including losses relating to both the Standby Facility and the Geelong Facility, and consequential losses from the Australian business’s termination and sale.
How Did the Court Analyse the Issues?
The court’s analysis was structured around the plaintiffs’ three causes of action and the evidential record. A central feature of the case was the legal status of the Standby Facility. After the trial, the Court of Appeal in The Enterprise Fund III Ltd v OUE Lippo Healthcare Ltd [2019] 2 SLR 524 held that the Standby Facility was void under s 76A(1)(a) of the Companies Act for contravention of s 76(1A)(a)(i). That appellate determination was highly pertinent because it established that the arrangement fell within a statutory prohibition relating to financial assistance and the acquisition of a company’s own shares.
In practical terms, the High Court had to consider how statutory illegality affected the plaintiffs’ claims in equity and tort. Where a transaction is void for contravention of company law, the court may treat the illegality as evidence of improper purpose and as a factor supporting findings of breach of duty, dishonest assistance, and unlawful means for conspiracy. The High Court’s reasoning therefore likely integrated the Court of Appeal’s observations to assess whether the defendants’ conduct was inconsistent with lawful corporate governance and whether it demonstrated the requisite mental element for accessory liability and conspiracy.
On breach of duty, the court would have examined the roles of Mr Fan and Ms Lim in the genesis and execution of the Standby Facility. The judgment extract highlights the early events: a meeting on 3 April 2015 and subsequent emails on 4 April 2015. The first 4 April email described an “unusual sale pattern” and a “shortist” attack, and requested a “standby line” of S$20 million. The second 4 April email (partially reproduced in the extract) indicated that Mr Aathar could provide a firm undertaking from IHC. These communications were likely treated as contemporaneous evidence of the purpose and intended use of the facility, and as indicators of whether the stated defensive rationale was genuine or a cover for an improper objective.
On dishonest assistance, the court would have focused on the Crest entities’ knowledge and participation. The fact that Mr Tan was the main representative handling Crest’s dealings with IHC since incorporation suggests that Crest had repeated opportunities to understand the commercial context and the intended use of funds. The court would also have considered whether the Crest entities’ documentation, negotiation positions, and implementation steps were consistent with a legitimate standby financing arrangement or with an arrangement designed to facilitate indirect share acquisition. The presence of personal guarantees and share charges over IHC’s subsidiaries further indicates that the financing was structured to secure repayment and collateralize the risk, which may have been assessed in light of the alleged improper purpose.
On conspiracy, the court would have analysed whether there was a common design among the defendants to injure IHC by unlawful means. The “unlawful means” element would have been tied to the statutory illegality and/or other breaches of law. The court would also have required proof of causation: that the defendants’ conspiracy caused or materially contributed to the losses claimed. The plaintiffs’ case linking the Standby Facility dispute to default under the Geelong Facility is relevant here because it provides a chain of causation connecting the alleged wrongdoing to subsequent financial consequences.
Finally, the judgment also dealt with remedies and quantum. The case metadata indicates that equitable compensation, rectification, unjust enrichment, and damages assessment were all in play. This suggests that the court considered multiple remedial frameworks, including how to quantify losses where the underlying transaction is void. The bifurcation of one category of loss relating to the termination and sale of the Australian business indicates that the court separated issues of liability from complex valuation and causation questions for that consequential loss.
What Was the Outcome?
The extract does not include the dispositive orders, but the judgment’s structure and the Court of Appeal’s prior ruling on the Standby Facility being void strongly suggest that the High Court found substantial liability against at least some defendants, particularly in relation to the improper use of the Standby Facility and the resulting losses. The court’s engagement with breach of duty, dishonest assistance, and conspiracy indicates that it was prepared to characterise the defendants’ conduct as unlawful and culpable, rather than merely a commercial dispute.
In terms of practical effect, the outcome would have determined (i) which defendants were liable for the losses connected to the Standby Facility and the Geelong Facility, (ii) whether equitable remedies such as equitable compensation were ordered, and (iii) how damages were assessed for consequential losses, including those arising from the termination and sale of IHC’s Australian business. The bifurcation indicates that the court’s final quantification may have been staged, with separate determination for specific loss categories.
Why Does This Case Matter?
This case matters because it illustrates how Singapore courts treat corporate financing arrangements that are used to circumvent statutory company law prohibitions. The Court of Appeal’s finding that the Standby Facility was void for contravention of the Companies Act provides a powerful legal backdrop. The High Court’s subsequent analysis of directors’ duties, dishonest assistance, and conspiracy demonstrates that statutory illegality can have far-reaching consequences beyond invalidity of the transaction itself, extending into personal liability and accessory liability in equity and tort.
For practitioners, the decision is also a reminder that liability can attach even where the wrongdoing is implemented through complex structures involving funds, intermediaries, and collateral arrangements. The involvement of sophisticated financing entities and the presence of contemporaneous emails about “shortist” attacks show how courts may scrutinise narrative explanations and assess whether they align with the actual commercial and legal effect of the transaction.
From a research perspective, the case is valuable for understanding the interplay between (i) company law constraints on financial assistance and share acquisition, (ii) equitable doctrines of dishonest assistance and accessory liability, and (iii) tortious conspiracy by unlawful means. It also signals that courts may integrate appellate findings on statutory voidness into the assessment of liability and remedies in subsequent proceedings.
Legislation Referenced
- Bankruptcy Act (Cap 20, 2009 Rev Ed)
- Companies Act (Cap 50, 2006 Rev Ed), including ss 76(1A)(a)(i) and 76A(1)(a)
Cases Cited
- [2010] SGHC 163
- [2014] SGHC 205
- [2019] 2 SLR 524 (The Enterprise Fund III Ltd and others v OUE Lippo Healthcare Ltd (formerly known as International Healthway Corp Ltd))
- [2020] SGHC 142 (this case)
Source Documents
This article analyses [2020] SGHC 142 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.